When Antibodies Incorporated opened its doors in 1962, antibody-related research was in its nascence. Founder Jim Hillman, having received a Ph.D. in pharmacology from the University of Minnesota, arrived at UC Davis to complete post-doctoral work in immunochemistry, which he had studied while working at the California Institute of Technology (Caltech) under Dan Campbell, a pioneer of the field.
Jim brought with him his wife Carol, a co-Founder of the company, and two children, as well as energy and ideas for finding cures for cancer using antibody-based chemotherapies. Specifically, Jim felt that if he could identify and isolate the parts of a tumor (one focus was lymphosarcomas) that might be antigenic, an effective antibody-based treatment might be possible. Jim’s dream to find cures of this kind drove his work for many years.